Asceneuron Awarded Second Grant from The Michael J. Fox Foundation for Accelerated Research into Novel Parkinson’s Disease Therapies
- Wednesday, May 4, 2022, 2:26
- Business
- Add a comment
LAUSANNE, Switzerland and SAN FRANCISCO, May 4, 2022 /PRNewswire/ — Asceneuron SA, a clinical stage company dedicated to targeting the root causes of neurodegenerative diseases, today announces that it has been awarded a second grant from The Michael J. Fox Foundation for Parkinson’s…
About the Author
adminasapcorp has written 41538 stories on this site.